MENAHRA
MENAHRA is a Beirut-based non-profit association founded in 2007 that delivers harm reduction, HIV/HCV prevention, and capacity-building programs across 20 Middle East and North African countries, funded by international donors and partnering with national health ministries.
- Company typePrivate
- Founded2007
- HeadquartersBeirut, Lebanon
- Headcount11–50
- GTM typeB2B
- OfferingServices
What MENAHRA does
MENAHRA (Middle East and North Africa Harm Reduction Association) is a Beirut-headquartered non-profit regional association founded in 2007 that delivers harm reduction programming across 20 Middle East and North African countries. Its work spans Opioid Substitution Therapy (OST), Needle and Syringe Programmes (NSP), HIV and Hepatitis C prevention, tuberculosis efforts, capacity building for civil society and health workers, and policy advocacy with national ministries of health and global bodies including WHO and UNDP. Operationally, MENAHRA runs a hub-and-spoke model with three Sub-Regional Knowledge Hubs in Iran, Lebanon, and Morocco, supported by a workforce of approximately 13 employees and a network of country-level implementing partners.
The organization functions as a coordinating layer between grassroots harm reduction actors, government health authorities, and international donors, including UNITAID, the Global Fund, the Robert Carr Fund, and Frontline AIDS. Notable recent programmatic vehicles include the UNITAID-funded Hepatitis C III project delivered in partnership with Frontline AIDS, the consolidated AJEM Opioid Substitution Therapy programme, and Training of Trainers workshops on OST delivered in countries such as Jordan. A purpose-built Donors Database platform has been introduced to systematize fundraising intelligence and broaden the donor pipeline.
MENAHRA's revenue model is grant-driven rather than commercial. Income is sourced from international donors and bilateral/multilateral grants earmarked for specific programmatic work, with no commercial pricing model or revenue from end-user beneficiaries. The 2022-2027 Strategic Plan sets the current multi-year direction, and the organization's competitive position rests on its regional convening role, ministerial access, and nearly two decades of institutional credibility in a politically sensitive public health domain.
MENAHRA firmographics
Firmographics- Name
- MENAHRA
- Legal name
- Middle East and North Africa Harm Reduction Association
- Website
- https://menahra.org
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MENAHRA is a Beirut-based non-profit association founded in 2007 that delivers harm reduction, HIV/HCV prevention, and capacity-building programs across 20 Middle East and North African countries, funded by international donors and partnering with national health ministries.
- Ownership category
- akta.pro rank
MENAHRA industry classification
Industry- Product category
- Harm Reduction and Public Health Services
- NAICS
- Individual and Family Services (6241), Voluntary Health Organizations (813212), Social Assistance (624)
- SIC
- Services-Social Services (8300), Services-Health Services (8000)
- akta.pro primary industry
- Substance Use Disorder Prevention & Recovery Services (BPAGACAE)
- akta.pro secondary industries
- Substance Use Recovery & Harm Reduction Support Services (BPAGAEAO), Behavioral Health & Substance Use Public Health Programs (BPAIAJAK), Disease-Specific Global Programs (HIV/TB/Malaria/NTDs) (HLAJAKAF)
Keywords
Where MENAHRA is headquartered
LocationHeadquarters
- HQ city
- Beirut
- HQ country
- Lebanon
- HQ region
- Middle East
Offices4 records
Markets served
MENAHRA business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- International Grants and Donations: MENAHRA operates as a non-profit regional network funded by international donors including UNITAID, Global Fund, and other international health organizations to implement harm reduction programs across the MENA region.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels6 records
MENAHRA product offering
Product offeringCore offering
MENAHRA coordinates and delivers harm reduction programs across 20 MENA countries, including Opioid Substitution Treatment (OST) using buprenorphine/Suboxone, Needle and Syringe Programs (NSP), Hepatitis C prevention and treatment integration (Hep C III project), training of trainers and capacity building for civil society and healthcare workers, and advocacy campaigns such as Support Don't Punish. It operates as a non-profit regional association funded by international donors (UNITAID, Global Fund, Robert Carr Fund) and works through implementing NGO partners and government health ministries.
Product overview
MENAHRA (Middle East Harm Reduction Association) operates as a regional harm reduction network rather than a traditional software product company. The organization offers a suite of interconnected programs and platforms including its main website, a donors database platform, newsletter publications, and various health service programs. Core offerings include Opioid Substitution Treatment (OST) programs using buprenorphine/Suboxone, Needle and Syringe Programs (NSP), and the UNITAID-funded Hep C III research project. The organization also coordinates the Support Don't Punish advocacy campaign and provides training and capacity building services. All offerings are public health focused and operate through partnerships with NGOs, governments, and international organizations across 20 MENA countries.
Differentiator
Problem solved
Functional benefit
Brands
- MENA Regional Learning Hub: A regional learning hub established by MENAHRA to provide capacity building, training resources, and knowledge sharing for harm reduction practitioners across the MENA region.
- MENAHRA Donors Database
Products and services
- Opioid Substitution Treatment (OST) Program
- Needle and Syringe Program (NSP)
Quantifiable outcome
- Needle and syringe programs reduced HIV infection rate by 18.6% annually in cities with NSP implementation (based on global evidence)
- +1 more outcomes
Companies that use MENAHRA
Customer profileNamed customers8 records
Segments6 records
Ideal customer profiles4 records
MENAHRA technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MENAHRA partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core, major and minor.
- SIDC LebanoncoreSoins Infirmiers et Développement Communautaire - key implementing partner in Lebanon providing harm reduction services, OST, and support for people who use drugs and people living with HIV. Hosts Sub-Regional Knowledge Hub.
- SKOUNmajorLebanese Addictions Center providing addiction treatment services and harm reduction advocacy
- Justice and Mercy Association (عدل ورحمة)majorCivil society partner for harm reduction training in Lebanon, participating in regional OST training of trainers program
- SQCUN (Skoun)majorNational NGO partner in Lebanon participating in opioid substitution therapy training
- National Association for Comprehensive Care (ANCS)minorCivil society organization participating in harm reduction training programs
- Jordanian Ministry of HealthcoreOrganized harm reduction and opiate substitution workshop in Amman, Jordan from March 5-7, 2024. Committed to organizing additional training sessions for professional development.
- Lebanese Ministry of Public HealthcoreCollaborates with and operates under supervision of Ministry for Opioid Substitution Treatment (OST) program implementation. AJEM's OST program operates under MOPH supervision with prescription books obtained from the ministry.
- Frontline AIDScoreFrontline AIDS leads the Hep C III project on Hepatitis C prevention through community-led harm reduction. MENAHRA serves as regional coordinator providing technical assistance in Egypt and other MENA countries. The four-year project focuses on integrating HCV testing and treatment within harm reduction programs.
- UNDP (United Nations Development Programme)majorCollaboration on adapting Hep C III project protocols and securing local ethical approvals for implementation in Egypt
- World Health Organization (WHO)majorWHO collaboration on Hep C III project protocols and integration with global health guidelines
- Egyptian Ministry of HealthcorePartner for Hep C III project implementation. Working closely with government to design research implementation structure that complements ongoing HCV and HIV programming within existing ministry frameworks.
- Frontline AIDScoreImplementing partner for harm reduction programs in the MENA region
- Stop TB PartnershipmajorPartnership for addressing tuberculosis among key populations in the MENA region
- International Drug Policy Consortium (IDPC)majorCoordinates Support Don't Punish campaign in MENA region - a global campaign launched by IDPC (London) to raise awareness around risks of criminalization of drug users
- MENANPUD (MENA Network of People Who Use Drugs)coreRegional network of people who use drugs that coordinates advocacy activities and campaign support in the MENA region
Scale indicators3 records
Recent moves8 records
Expansion highlights5 records
MENAHRA competitors and assessment
Company assessmentBroad incumbents
- AIDS Healthcare Foundation (AHF): Large global HIV/AIDS and key populations service provider operating in many MENA countries; offers overlapping HIV testing/treatment and harm reduction capabilities but as part of a much broader global healthcare portfolio.
- Médecins du Monde (Doctors of the World): International humanitarian NGO delivering harm reduction, NSP, OST and health services for vulnerable populations including PWUD; comparable service model with MENA operations but broader healthcare mandate.
- WHO Eastern Mediterranean Regional Office (EMRO): Multilateral public health agency covering MENA region, partnering with MENAHRA on Hep C III protocols and broader harm reduction guidelines; comparable regional health remit but as a governmental multilateral rather than civil society network.
Direct peers
- Frontline AIDS: Partnership-based organization working on HIV, key populations and harm reduction; MENAHRA is regional coordinator for the Frontline AIDS-led UNITAID Hep C III project, making it a closely aligned peer and downstream partner.
- International Drug Policy Consortium (IDPC): Global network promoting drug policy reform and harm reduction, originator of the Support Don't Punish campaign that MENAHRA coordinates regionally; comparable advocacy mandate and coalition-based operating model.
- International Network of People Who Use Drugs (INPUD): Global peer-led network of people who use drugs advocating for health, human rights and harm reduction; structurally parallel to MENAHRA's MENANPUD affiliate and its community-led model for PWUD advocacy in MENA.
- Harm Reduction International (HRI): Global harm reduction advocacy and capacity building organization focused on drug policy reform and evidence-based interventions for people who use drugs; directly comparable to MENAHRA's advocacy, training and policy mandate but operating at a global rather than regional scope.
- Correlation Network: European harm reduction network focused on drug user community health, peer-led programming and policy advocacy; comparable regional network structure and harm reduction focus to MENAHRA but operating in Europe.
- SIDC Lebanon: Leading Lebanese harm reduction NGO and MENAHRA sub-regional knowledge hub host; directly delivers NSP, OST and HIV support to PWUD in Lebanon with very similar programmatic and beneficiary focus.
- SKOUN Lebanese Addictions Center: Lebanese addiction treatment and harm reduction NGO that is a MENAHRA implementing partner; provides comparable outpatient addiction treatment and harm reduction services in Lebanon.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
MENAHRA social profiles
Digital presenceMENAHRA financial estimates
Financial estimateRevenue estimate
Valuation estimate
MENAHRA leadership team
Management profileNumber of profiles
Profiles7 records
MENAHRA subsidiaries and ownership
Company hierarchySubsidiaries3 records
MENAHRA funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MENAHRA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MENAHRA
What does MENAHRA do?
MENAHRA coordinates and delivers harm reduction programs across 20 MENA countries, including Opioid Substitution Treatment (OST) using buprenorphine/Suboxone, Needle and Syringe Programs (NSP), Hepatitis C prevention and treatment integration (Hep C III project), training of trainers and capacity building for civil society and healthcare workers, and advocacy campaigns such as Support Don't Punish. It operates as a non-profit regional association funded by international donors (UNITAID, Global Fund, Robert Carr Fund) and works through implementing NGO partners and government health ministries.
Is MENAHRA a public or private company?
MENAHRA is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was MENAHRA founded?
MENAHRA was founded in 2007. It employs 11 to 50 people.
Where is MENAHRA based?
MENAHRA is headquartered in Beirut, Lebanon, in the Middle East region.
How does MENAHRA make money?
One revenue line is on record: international Grants and Donations.
Who are MENAHRA's main competitors?
Broad incumbents on record are AIDS Healthcare Foundation (AHF), Médecins du Monde (Doctors of the World) and WHO Eastern Mediterranean Regional Office (EMRO). Direct peers are Frontline AIDS, International Drug Policy Consortium (IDPC), International Network of People Who Use Drugs (INPUD), Harm Reduction International (HRI), Correlation Network, SIDC Lebanon and SKOUN Lebanese Addictions Center.
Does MENAHRA have an API?
No public API is recorded for MENAHRA.
What industry is MENAHRA in?
MENAHRA's product category is Harm Reduction and Public Health Services. Its primary akta.pro industry code is BPAGACAE, Substance Use Disorder Prevention & Recovery Services, with a secondary code of BPAGAEAO, Substance Use Recovery & Harm Reduction Support Services. Its NAICS code is 6241 and its SIC code is 8300.